GERNGERON CORP

Nasdaq geron.com


$ 3.88 $ 0.07 (1.84 %)    

Thursday, 09-May-2024 15:59:44 EDT
QQQ $ 442.15 $ -0.77 (-0.17 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 521.52 $ 0.00 (0 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 219.78 $ 0.00 (0 %)
$ 3.88
$ 3.82
$ 0.00 x 0
$ 0.00 x 0
$ 3.80 - $ 3.91
$ 1.64 - $ 4.30
5,618,215
na
2.34B
$ 0.44
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-16-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-10-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-11-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-28-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 03-07-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 07-31-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-16-2018 12-31-2017 10-K
27 11-01-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 03-01-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-03-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 03-10-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-11-2015 12-31-2014 10-K
39 11-05-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-buy-on-geron-maintains-5-price-target

Needham analyst Gil Blum reiterates Geron (NASDAQ:GERN) with a Buy and maintains $5 price target.

 geron-q1-2024-gaap-eps-009-beats-010-estimate-sales-304000k-beat-24714k-estimate

Geron (NASDAQ:GERN) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 p...

 baird-downgrades-geron-to-neutral-maintains-45-price-target

Baird analyst Joel Beatty downgrades Geron (NASDAQ:GERN) from Outperform to Neutral and maintains $4.5 price target.

 td-cowen-initiates-coverage-on-geron-with-buy-rating-announces-price-target-of-10

TD Cowen analyst Tara Bancroft initiates coverage on Geron (NASDAQ:GERN) with a Buy rating and announces Price Target of $10.

 argan-reports-upbeat-earnings-joins-coupang-and-other-big-stocks-moving-higher-on-friday

U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sh...

 jim-cramer-this-tech-stock-is-great-archer-aviation-is-too-speculative-for-me

On CNBC’s "Mad Money Lightning Round," Jim Cramer said "no" to MarineMax Inc (NYSE: HZO).

 needham-reiterates-buy-on-geron-maintains-5-price-target

Needham analyst Gil Blum reiterates Geron (NASDAQ:GERN) with a Buy and maintains $5 price target.

 wedbush-reiterates-outperform-on-geron-maintains-6-price-target

Wedbush analyst Robert Driscoll reiterates Geron (NASDAQ:GERN) with a Outperform and maintains $6 price target.

 geron-corporation-announces-pricing-of-150m-underwritten-offering-of-common-stock-and-pre-funded-warrants

Geron Corporation (NASDAQ:GERN), a late-stage clinical biopharmaceutical company, today announced the pricing of an underwritte...

 stat-news-adam-feuerstein-publishes-i-was-wrong-about-gerons-blood-cancer-drug-now-is-it-a-takeover-target-shares-see-volume

https://www.statnews.com/2024/03/18/geron-blood-cancer-drug-takeover-target/ I was wrong about Geron. For years, I’ve believed...

 why-nuvei-shares-are-trading-higher-by-around-14-here-are-20-stocks-moving-premarket

Shares of Nuvei Corp (NASDAQ: NVEI) rose sharply in today’s pre-market trading following a report indicating the company is in...

 logitech-b-riley-financial-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining by around 100 points on Monday. Shares of ...

 inflation-squeezes-stocks-bitcoin-slips-to-68000-while-commodities-on-track-for-best-week-in-months-whats-driving-markets-friday

Wall Street continues to maintain a risk-off sentiment in Friday’s session, echoing the pessimism triggered by Thursday’s unexp...

 needham-maintains-buy-on-geron-raises-price-target-to-5

Needham analyst Gil Blum maintains Geron (NASDAQ:GERN) with a Buy and raises the price target from $4 to $5.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION